Neurostimulation Devices Market Analysis, Market Size, Application Analysis, Regional Outlook, Competitive Strategies and Forecasts, 2014 to 2020

Submitted by: Submitted by

Views: 10

Words: 882

Pages: 4

Category: Business and Industry

Date Submitted: 08/27/2015 10:53 PM

Report This Essay

Hexa Research Inc.

Industry Research,Custom Research & Consulting

Neurostimulation Devices Market Size, Market Share,

Application Analysis, Regional Outlook, Growth, Trends,

Competitive Scenario and Forecasts, 2012 To 2020

Industry Insights

Growing geriatric population base and rising incidences of target diseases such as Alzheimer’s

and Parkinson’s are the major drivers for this market. As per an estimate by the Alzheimer

Disease International 36 million people globally had Alzheimer’s or a related dementia. Limited

treatment options for diseases such as migraine and epilepsy has led to high unmet medical needs

of patients in this segment, and thus is a high impact rendering driver for the neurostimulation

devices market. Spurred use of neuromodulation devices as an add-on therapy, growing demand

for minimally invasive surgery and the technological advancements such as Neurowave Medical

Technologies transdermal neuromodulation technology and MRI safety enabled neurostimulator

by Medtronic, are expected to further augment the growth of the neurostimulation devices.

Browse Detail Report with TOC @ http://www.hexaresearch.com/research-report/neurostimulationdevices-industry/

Product Insights

The products analyzed in the neurostimulation devices market include gastric electric stimulation

device, deep brain stimulation device, vagus nerve stimulation device, spinal cord stimulation

Hexa Research Inc.

Industry Research,Custom Research & Consulting

device and sacral nerve stimulation device. Spinal cord stimulation devices dominated the

neurostimulation devices market in 2012 with over 60.0% revenue share. These devices hold a

competitive edge over the other devices as they were the first to be commercialized, and thus

have higher penetration rates. High prevalence of chronic pain, cost effectiveness in terms of

quality adjusted life years are the major drivers for this segment. Deep brain stimulation devices

held the second largest revenue share; these devices are...